Griffin-American Healthcare REIT III Acquires Acworth

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Griffin-American Healthcare REIT III Acquires Acworth Medical Complex Near Atlanta

ATLANTA, July 9, 2014 (GLOBE NEWSWIRE) -- American Healthcare Investors and Griffin Capital Corporation, the co-sponsors of Griffin-American Healthcare REIT III, Inc., announced today that the REIT has acquired Acworth Medical Complex, an approximately 39,000-square-foot medical office building in the Atlanta suburb of Acworth.

Located at 4769, 4791 and 4797 South Main Street, Acworth Medical Complex is approximately 83 percent leased to four tenants, including Emory Specialty Associates LLC, a wholly owned subsidiary of Emory Healthcare, Northside Hospital and Eldercare Pharmacy, which in the aggregate lease approximately 69 percent of the space through June 2020. A number of medical services are provided at the building, including: pharmacological, nursing, cardiac imaging and cancer care.

Emory Healthcare, the building's principal tenant, is the largest comprehensive healthcare system in Georgia, with 1,830 licensed patient beds, 9,000 employees and more than 20 health centers located throughout Greater Atlanta. Emory has an Aa2 credit rating, as provided by Moody's Corporation.

"Acworth Medical Complex is affiliated with two of Atlanta's most prestigious hospital systems in Emory and Northside," said Dan Prosky, a principal of American Healthcare Investors and president and chief operating officer of Griffin-American Healthcare REIT III. "Additionally, it is both an attractive and modern medical office building, having undergone a comprehensive renovation in 2009." 

Acworth Medical Complex was acquired from unaffiliated third party investors represented by Spencer Coan of SK Commercial Realty. Griffin-American Healthcare REIT III financed the acquisition using cash on hand.  

About American Healthcare Investors LLC

American Healthcare Investors is an investment management firm that specializes in the acquisition and management of healthcare-related real estate, including medical office buildings, skilled nursing facilities, senior housing and hospitals. The company was founded by nationally recognized real estate investment executives Jeff Hanson, Danny Prosky and Mathieu Streiff, who have completed in excess of $18 billion in aggregate acquisition and disposition transactions during their careers, approximately $8 billion of which has been healthcare-related real estate transactions. American Healthcare Investors is committed to providing investors with access to the potential benefits that healthcare-related real estate ownership can provide. For more information regarding American Healthcare Investors, please visit www.AmericanHealthcareInvestors.com .

About Griffin-American Healthcare REIT III, Inc.

Griffin-American Healthcare REIT III, Inc. intends to qualify as a real estate investment trust for federal income tax purposes. Griffin-American Healthcare REIT III intends to build a balanced and diversified portfolio of healthcare real estate assets, focusing primarily on medical office buildings, senior housing facilities, skilled nursing facilities and hospitals. The REIT is co-sponsored by American Healthcare Investors and Griffin Capital Corporation . For more information regarding Griffin-American Healthcare REIT III, please visit www.HealthcareREIT3.com .

About Griffin Capital Corporation

Griffin Capital is a privately-owned real estate company headquartered in Los Angeles. Led by senior executives, each with more than two decades of real estate experience who have collectively closed transactions representing over $16 billion in value, Griffin Capital and affiliates have acquired or constructed over 30 million square feet of space since 1995, and currently own, manage, sponsor and/or co-sponsor an institutional-quality portfolio of approximately 27 million square feet located in 32 states and 1 million square feet located in the United Kingdom, representing approximately $5.2 billion in asset value, based on purchase price. Additional information about Griffin Capital is available at www.griffincapital.com .

This release contains certain forward-looking statements, including statements with respect to the occupancy of Acworth Medical Complex. Because such statements include risks, uncertainties and contingencies, actual results may differ materially from those expressed or implied by such forward-looking statements. These risks, uncertainties and contingencies include, but are not limited to, the following: the uncertainties relating to the medical needs and local economy of Acworth, Georgia; the strength and financial condition of Acworth Medical Complex and its tenants; the success of Emory Healthcare and Northside Hospital; the uncertainties relating to changes in general economic and real estate conditions; the uncertainties regarding changes in the healthcare industry; the uncertainties relating to the implementation of Griffin-American Healthcare REIT III's real estate investment strategy; and other risk factors as outlined in that company's prospectus, as amended from time to time, and as detailed from time to time in Griffin-American Healthcare REIT III's periodic reports, as filed with the Securities and Exchange Commission. Forward-looking statements in this document speak only as of the date on which such statements were made, and we undertake no obligation to update any such statements that may become untrue because of subsequent events.

Damon Elder (949) 270-9207

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 425

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 86

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 422

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 9

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 268

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 323

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 123

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 15

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 175

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 340

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading

Top 5 Most Recently Viewed Articles

Laugh Factory's Annual Free Thanksgiving Feast Returns to Hollywood

Updated Category News Views 239

Laugh Factory's Holiday Tradition: A Thanksgiving Feast The world-renowned Laugh Factory in Hollywood proudly continues its cherished tradition by hosting the 45th consecutive annual free Thanksgiving feast. This Thanksgiving, the club opens its doors for four seatings at 1 p.m., 3 p.m., 5 p.m., and 7 p.m., offering an incredible opportunity for community members to come...

Continue Reading
Recognizing Thomas Edwards Jr.: A Champion of Justice

Updated Category News Views 275

Celebrating Excellence in Legal Advocacy Attorney Thomas S. Edwards, Jr., a Senior Partner at Edwards & Ragatz, P.A., has been honored with the prestigious "Compassionate Gladiator Award" by the Florida Justice Association (FJA). This esteemed award is presented to legal professionals who exhibit exceptional dedication to their clients and the legal system, reflecting the...

Continue Reading
Growth Journey of Plant-Based Dairy: Trends and Insights

Updated Category News Views 283

Exploring the Plant-Based Dairy Products Market The plant-based dairy products market is witnessing remarkable growth, driven by evolving consumer preferences and increasing awareness regarding health benefits and sustainability practices. Initially valued at USD 20 billion, market experts project it to reach USD 34 billion by 2030, fueled by a promising CAGR of 9%...

Continue Reading
Catch the Excitement of Monster Jam at Northern Tool + Equipment

Updated Category News Views 138

Monster Jam Hits Northern Tool + Equipment in Oklahoma City Northern Tool + Equipment is thrilled to announce an upcoming event that promises to be packed with excitement and entertainment for the community. This special day will spotlight a legendary Monster Jam truck, bringing the high-octane thrill of motorsports to local fans. Exclusive Offers for Customers As part of...

Continue Reading
Analyzing NVIDIA’s Competitive Edge in Semiconductor Sector

Updated Category News Views 214

Understanding NVIDIA's Role in the Semiconductor Industry In the fast-paced world of technology, evaluation of companies within specific sectors is vital for investors and enthusiasts. This article focuses on NVIDIA (NASDAQ: NVDA), a leader in the Semiconductors & Semiconductor Equipment industry, and compares its performance with key competitors. By analyzing crucial...

Continue Reading